162 related articles for article (PubMed ID: 35052571)
21. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
[TBL] [Abstract][Full Text] [Related]
22. Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses.
Komaravelli N; Casola A
J Pharmacogenomics Pharmacoproteomics; 2014 Sep; 5(4):. PubMed ID: 25584194
[TBL] [Abstract][Full Text] [Related]
23. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion.
Cho JY; Miller M; Baek KJ; Castaneda D; Nayar J; Roman M; Raz E; Broide DH
J Allergy Clin Immunol; 2001 Nov; 108(5):697-702. PubMed ID: 11692091
[TBL] [Abstract][Full Text] [Related]
24. Role for innate IFNs in determining respiratory syncytial virus immunopathology.
Johnson TR; Mertz SE; Gitiban N; Hammond S; Legallo R; Durbin RK; Durbin JE
J Immunol; 2005 Jun; 174(11):7234-41. PubMed ID: 15905569
[TBL] [Abstract][Full Text] [Related]
25. Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.
Foronjy RF; Dabo AJ; Cummins N; Geraghty P
BMC Immunol; 2014 Oct; 15():41. PubMed ID: 25277705
[TBL] [Abstract][Full Text] [Related]
26. CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lungs.
Zhang L; Li H; Hai Y; Yin W; Li W; Zheng B; Du X; Li N; Zhang Z; Deng Y; Zeng R; Wei L
J Virol; 2017 May; 91(10):. PubMed ID: 28275186
[TBL] [Abstract][Full Text] [Related]
27. Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.
Cormier SA; Shrestha B; Saravia J; Lee GI; Shen L; DeVincenzo JP; Kim YI; You D
J Virol; 2014 Aug; 88(16):9350-60. PubMed ID: 24920801
[TBL] [Abstract][Full Text] [Related]
28. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus.
Ramaswamy M; Shi L; Monick MM; Hunninghake GW; Look DC
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):893-900. PubMed ID: 14722224
[TBL] [Abstract][Full Text] [Related]
29. Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.
Schijf MA; Lukens MV; Kruijsen D; van Uden NO; Garssen J; Coenjaerts FE; Van't Land B; van Bleek GM
PLoS One; 2013; 8(11):e81695. PubMed ID: 24303065
[TBL] [Abstract][Full Text] [Related]
30. [Effect of interferon-γ on airway inflammation following respiratory syncytial virus reinfection in mice].
Long XR; Xie J; Li W; Zhao KT; Xie XH; Wang LJ; Ren L; Liu EM; Deng Y
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):760-765. PubMed ID: 29050114
[No Abstract] [Full Text] [Related]
31. Preliminary
Chu KB; Lee HA; Kang HJ; Moon EK; Quan FS
Cells; 2020 May; 9(5):. PubMed ID: 32466130
[TBL] [Abstract][Full Text] [Related]
32. Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.
Han J; Jia Y; Takeda K; Shiraishi Y; Okamoto M; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2010 Aug; 182(4):455-63. PubMed ID: 20442434
[TBL] [Abstract][Full Text] [Related]
33. The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus.
Tahamtan A; Tavakoli-Yaraki M; Shadab A; Rezaei F; Marashi SM; Shokri F; Mokhatri-Azad T; Salimi V
Viral Immunol; 2018 May; 31(4):292-298. PubMed ID: 29461930
[TBL] [Abstract][Full Text] [Related]
34. Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.
Garofalo RP; Kolli D; Casola A
Antioxid Redox Signal; 2013 Jan; 18(2):186-217. PubMed ID: 22799599
[TBL] [Abstract][Full Text] [Related]
35. MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice.
Long X; Li S; Xie J; Li W; Zang N; Ren L; Deng Y; Xie X; Wang L; Fu Z; Liu E
Respir Res; 2015 Feb; 16(1):11. PubMed ID: 25652021
[TBL] [Abstract][Full Text] [Related]
36. Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma.
Matsuse H; Kondo Y; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Mizuta Y; Kohno S
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):55-60. PubMed ID: 16892782
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice.
Zang N; Li S; Li W; Xie X; Ren L; Long X; Xie J; Deng Y; Fu Z; Xu F; Liu E
Int Immunopharmacol; 2015 Sep; 28(1):121-8. PubMed ID: 26044349
[TBL] [Abstract][Full Text] [Related]
38. Autophagy, TGF-β, and SMAD-2/3 Signaling Regulates Interferon-β Response in Respiratory Syncytial Virus Infected Macrophages.
Pokharel SM; Shil NK; Bose S
Front Cell Infect Microbiol; 2016; 6():174. PubMed ID: 28018859
[TBL] [Abstract][Full Text] [Related]
39. PPAR-γ in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection.
Huang S; Zhu B; Cheon IS; Goplen NP; Jiang L; Zhang R; Peebles RS; Mack M; Kaplan MH; Limper AH; Sun J
J Virol; 2019 May; 93(9):. PubMed ID: 30787149
[TBL] [Abstract][Full Text] [Related]
40. Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.
Hillyer P; Shepard R; Uehling M; Krenz M; Sheikh F; Thayer KR; Huang L; Yan L; Panda D; Luongo C; Buchholz UJ; Collins PL; Donnelly RP; Rabin RL
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
